Ascorbic Acid for Skin Cancer

Recruiting in Palo Alto (17 mi)

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Phase < 1

Recruiting

Sponsor: Center for Biomedical Research, Inc.

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial tests a vitamin C solution and an approved cream for treating a specific type of skin cancer in adults. The vitamin C solution aims to kill cancer cells and reduce inflammation, while the cream boosts the immune system to fight cancer. Vitamin C has been studied for its various health benefits.

Eligibility Criteria

This trial is for adults with biopsy-proven squamous cell skin cancer. It's not suitable for those who've had other cancers, have diabetes, or are immunocompromised.

Inclusion Criteria

I have been diagnosed with squamous cell skin cancer through a biopsy.

Exclusion Criteria

I have had cancer before.

I have diabetes.

My immune system is weak.

Participant Groups

The study tests a topical solution of 30% ascorbic acid in DMSO against a standard treatment (5% imiquimod cream) to see which is better at clearing up squamous cell carcinomas of the skin over an 8-week period.

1Treatment groups

Experimental Treatment

Group I: 30% Ascorbic Acid in DMSOExperimental Treatment1 Intervention

Topical application twice daily of 300ul 30% (w/v) solution of ascorbic acid in DMSO